These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 37696544)

  • 1. Comparing research and development, launch, and scale up timelines of 18 vaccines: lessons learnt from COVID-19 and implications for other infectious diseases.
    Mao W; Zimmerman A; Urli Hodges E; Ortiz E; Dods G; Taylor A; Udayakumar K
    BMJ Glob Health; 2023 Sep; 8(9):. PubMed ID: 37696544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Future of Epidemic and Pandemic Vaccines to Serve Global Public Health Needs.
    Farlow A; Torreele E; Gray G; Ruxrungtham K; Rees H; Prasad S; Gomez C; Sall A; Magalhães J; Olliaro P; Terblanche P
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 vaccines and the pandemic: lessons learnt for other neglected diseases and future threats.
    Hotez PJ; Gilbert S; Saville M; Privor-Dumm L; Abdool-Karim S; Thompson D; Excler JL; Kim JH
    BMJ Glob Health; 2023 Jun; 8(6):. PubMed ID: 37277196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probability of Success and Timelines for the Development of Vaccines for Emerging and Reemerged Viral Infectious Diseases.
    MacPherson A; Hutchinson N; Schneider O; Oliviero E; Feldhake E; Ouimet C; Sheng J; Awan F; Wang C; Papenburg J; Basta NE; Kimmelman J
    Ann Intern Med; 2021 Mar; 174(3):326-334. PubMed ID: 33226855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors, enablers and challenges for COVID-19 vaccine development.
    Excler JL; Saville M; Privor-Dumm L; Gilbert S; Hotez PJ; Thompson D; Abdool-Karim S; Kim JH
    BMJ Glob Health; 2023 Jun; 8(6):. PubMed ID: 37277195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International Collaboration to Ensure Equitable Access to Vaccines for COVID-19: The ACT-Accelerator and the COVAX Facility.
    Eccleston-Turner M; Upton H
    Milbank Q; 2021 Jun; 99(2):426-449. PubMed ID: 33650737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global access to COVID-19 vaccines: a scoping review of factors that may influence equitable access for low and middle-income countries.
    Peacocke EF; Heupink LF; Frønsdal K; Dahl EH; Chola L
    BMJ Open; 2021 Sep; 11(9):e049505. PubMed ID: 34593496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Speeding Access to Vaccines and Medicines in Low- and Middle-Income Countries: A Case for Change and a Framework for Optimized Product Market Authorization.
    Ahonkhai V; Martins SF; Portet A; Lumpkin M; Hartman D
    PLoS One; 2016; 11(11):e0166515. PubMed ID: 27851831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which roads lead to access? A global landscape of six COVID-19 vaccine innovation models.
    Alonso Ruiz A; Bezruki A; Shinabargar E; Large K; Vieira M; Slovenski I; Liu Y; Agarwal S; Becker A; Moon S
    Global Health; 2024 Mar; 20(1):25. PubMed ID: 38532484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Race for Global Equitable Access to COVID-19 Vaccines.
    Md Khairi LNH; Fahrni ML; Lazzarino AI
    Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring future perspectives and pipeline progression in vaccine research and development.
    Vecchio R; Gentile L; Tafuri S; Costantino C; Odone A
    Ann Ig; 2024; 36(4):446-461. PubMed ID: 38436081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meeting Summary: Global Vaccine and Immunization Research Forum, 2021.
    Ford A; Hwang A; Mo AX; Baqar S; Touchette N; Deal C; King D; Earle K; Giersing B; Dull P; Hall BF
    Vaccine; 2023 Mar; 41(11):1799-1807. PubMed ID: 36803897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collaboration within the global vaccine safety surveillance ecosystem during the COVID-19 pandemic: lessons learnt and key recommendations from the COVAX Vaccine Safety Working Group.
    Chandler RE; Balakrishnan MR; Brasseur D; Bryan P; Espie E; Hartmann K; Jouquelet-Royer C; Milligan J; Nesbitt L; Pal S; Precioso A; Takey P; Chen RT;
    BMJ Glob Health; 2024 Mar; 9(3):. PubMed ID: 38453518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the COVID-19 vaccine market landscape in 2021 relative to challenges in low- and middle-income countries.
    Oddleifson DA; Kayani J; Shrivastava R; Tan J; Winters M; Forman H; Omer SB
    Hum Vaccin Immunother; 2022 Nov; 18(6):2124781. PubMed ID: 36269944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lessons learnt from COVID-19 to reduce mortality and morbidity in the Global South: addressing global vaccine equity for future pandemics.
    Martin R; Maleche A; Gay J; Fatima H
    BMJ Glob Health; 2024 Jan; 9(1):. PubMed ID: 38167259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 Vaccine Collaborative Supply Planning: Is This the Next Frontier for Routine Immunization Supply Chains?
    Akhlaghi L; Prosser W; Rakotomanga A; Makena J; Azubike T; Bello Y; Emelike S; Mothetsi L; Motuba M; Olayemi V; Samba S; Suh S; Ramaroson S; Yarro FDN
    Glob Health Sci Pract; 2024 Feb; 12(Suppl 1):. PubMed ID: 38378271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccines: New challenges, new paradigms, new opportunities: Report of the 22nd DCVMN Annual General Meeting.
    Kumar Suri R; Hayman B; Prasad SD; Makhoana M; Tippoo P
    Vaccine; 2022 Jun; 40(26):3495-3505. PubMed ID: 35577632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research priorities to reduce the impact of COVID-19 in low- and middle-income countries.
    Polašek O; Wazny K; Adeloye D; Song P; Chan KY; Bojude DA; Ali S; Bastien S; Becerra-Posada F; Borrescio-Higa F; Cheema S; Cipta DA; Cvjetković S; Castro LD; Ebenso B; Femi-Ajao O; Ganesan B; Glasnović A; He L; Heraud JM; Igwesi-Chidobe C; Iversen PO; Jadoon B; Karim AJ; Khan J; Biswas RK; Lanza G; Lee SW; Li Y; Liang LL; Lowe M; Islam MM; Marušić A; Mshelia S; Manyara AM; Htay MN; Parisi M; Peprah P; Sacks E; Akinyemi KO; Shahraki-Sanavi F; Sharov K; Rotarou ES; Stankov S; Supriyatiningsih W; Chan BT; Tremblay M; Tsimpida D; Vento S; Glasnović JV; Wang L; Wang X; Ng ZX; Zhang J; Zhang Y; Campbell H; Chopra M; Cousens S; Krstić G; Macdonald C; Mansoori P; Patel S; Sheikh A; Tomlinson M; Tsai AC; Yoshida S; Rudan I
    J Glob Health; 2022; 12():09003. PubMed ID: 35475006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supporting the pandemic response and timely access to COVID-19 vaccines: a case for stronger priority setting and health system governance in Nigeria.
    Chukwu OA; Kapiriri L; Essue B
    Int J Pharm Pract; 2022 Jun; 30(3):284-287. PubMed ID: 35468198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.